Phreesia/$PHR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Phreesia
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Ticker
$PHR
Sector
Primary listing
NYSE
Industry
Health Care Technology
Headquarters
Employees
2,082
ISIN
US71944F1066
Website
Phreesia Metrics
BasicAdvanced
$1.7B
-
-$0.73
0.74
-
Price and volume
Market cap
$1.7B
Beta
0.74
52-week high
$30.53
52-week low
$17.07
Average daily volume
656K
Financial strength
Current ratio
1.946
Quick ratio
1.499
Long term debt to equity
2.326
Total debt to equity
5.623
Interest coverage (TTM)
-16.58%
Profitability
EBITDA (TTM)
-19.838
Gross margin (TTM)
68.02%
Net profit margin (TTM)
-9.83%
Operating margin (TTM)
-8.51%
Effective tax rate (TTM)
-7.39%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
-5.98%
Return on equity (TTM)
-15.97%
Valuation
Price to revenue (TTM)
3.837
Price to book
6.04
Price to tangible book (TTM)
13.58
Price to free cash flow (TTM)
76.071
Free cash flow yield (TTM)
1.31%
Free cash flow per share (TTM)
37.69%
Growth
Revenue change (TTM)
16.29%
Earnings per share change (TTM)
-65.83%
3-year revenue growth (CAGR)
23.93%
3-year earnings per share growth (CAGR)
-37.96%
What the Analysts think about Phreesia
Analyst ratings (Buy, Hold, Sell) for Phreesia stock.
Bulls say / Bears say
Phreesia reported a 15% year-over-year increase in Q4 fiscal 2025 revenue, reaching $109.7 million, indicating strong growth momentum. (stocktitan.net)
The company's net loss significantly decreased to $6.4 million in Q4 fiscal 2025 from $30.6 million the previous year, reflecting improved financial health. (stocktitan.net)
Phreesia's client base expanded by 10% to 4,341 healthcare services clients in Q4 fiscal 2025, showcasing successful market penetration. (stocktitan.net)
Insider selling activity, including the General Counsel's sale of 1,213 shares in April 2025, may raise concerns about internal confidence. (techdows.com)
Despite revenue growth, Phreesia reported a net loss of $58.5 million for fiscal 2025, indicating ongoing profitability challenges. (stocktitan.net)
The company's stock price has experienced volatility, with a 52-week range between $17.07 and $30.53, which may concern risk-averse investors. (techdows.com)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.
Phreesia Financial Performance
Revenues and expenses
Phreesia Earnings Performance
Company profitability
Phreesia News
AllArticlesVideos
Phreesia Named in Black Book Research's List of 2025's Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management
Business Wire·2 days ago
Becker's Names Phreesia's Kristin Roberts as one of 2025's 100 Women in Health IT to Know
Business Wire·4 weeks ago
Phreesia Announces First Quarter Fiscal 2026 Results
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Phreesia stock?
Phreesia (PHR) has a market cap of $1.7B as of July 11, 2025.
What is the P/E ratio for Phreesia stock?
The price to earnings (P/E) ratio for Phreesia (PHR) stock is 0 as of July 11, 2025.
Does Phreesia stock pay dividends?
No, Phreesia (PHR) stock does not pay dividends to its shareholders as of July 11, 2025.
When is the next Phreesia dividend payment date?
Phreesia (PHR) stock does not pay dividends to its shareholders.
What is the beta indicator for Phreesia?
Phreesia (PHR) has a beta rating of 0.74. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.